Who Holds Artiva Biotherapeutics, Inc. (ARTV)? 72 Institutional Holders, Q2 2026
Managers with more than $100 million in US equities report their holdings on Form 13F within 45 days of each quarter end. Quarter ended 30 Jun 2026: 72 holders, $391 million in total.
Largest holders
The 72 largest by value. Change in shares against Q1 2026.
| Manager | Shares | Value | Change | |
|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 17,955,642 | $174 million | +82% | 13F |
| VIKING GLOBAL INVESTORS LP | 2,604,166 | $25 million | New | 13F |
| Blackstone Inc. | 2,403,437 | $23 million | New | 13F |
| 5AM Venture Management, LLC | 2,353,304 | $23 million | +0% | 13F |
| Venrock Adviser, LLC | 2,043,596 | $20 million | +27% | 13F |
| FRANKLIN RESOURCES INC | 1,997,223 | $19 million | +284% | 13F |
| Caligan Partners LP | 1,736,111 | $17 million | New | 13F |
| VANGUARD CAPITAL MANAGEMENT LLC | 981,815 | $10 million | +373% | 13F |
| SAMSARA BIOCAPITAL, LLC | 954,861 | $9 million | New | 13F |
| Blue Owl Capital Holdings LP | 874,542 | $8 million | New | 13F |
| Propel Bio Management, LLC | 696,436 | $7 million | +376% | 13F |
| BlackRock, Inc. | 694,726 | $7 million | +226% | 13F |
| CITADEL ADVISORS LLC | 609,376 | $6 million | +3740% | 13F |
| SILVERARC CAPITAL MANAGEMENT, LLC | 525,000 | $5 million | New | 13F |
| GEODE CAPITAL MANAGEMENT, LLC | 353,845 | $3 million | +248% | 13F |
| BOOTHBAY FUND MANAGEMENT, LLC | 314,375 | $3 million | New | 13F |
| Nantahala Capital Management, LLC | 300,000 | $3 million | New | 13F |
| Revelation Capital Management, LLC | 299,311 | $3 million | +0% | 13F |
| Alyeska Investment Group, L.P. | 273,615 | $3 million | +174% | 13F |
| ACUTA CAPITAL PARTNERS, LLC | 260,416 | $3 million | New | 13F |
| KVP Capital Advisors, LP | 200,000 | $2 million | New | 13F |
| WELLINGTON MANAGEMENT GROUP LLP | 194,108 | $2 million | +0% | 13F |
| UBS Group AG | 184,020 | $2 million | +11951% | 13F |
| SEVEN GRAND MANAGERS, LLC | 175,000 | $2 million | New | 13F |
| STATE STREET CORP | 165,764 | $2 million | +363% | 13F |
| RENAISSANCE TECHNOLOGIES LLC | 151,000 | $1 million | +89% | 13F |
| VANGUARD FIDUCIARY TRUST CO | 148,393 | $1 million | +352% | 13F |
| ADAR1 Capital Management, LLC | 118,624 | $1 million | New | 13F |
| Simplify Asset Management Inc. | 101,355 | $983,144 | +336% | 13F |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 85,000 | $824,500 | +143% | 13F |
| TWO SIGMA INVESTMENTS, LP | 78,575 | $762,178 | -32% | 13F |
| NORTHERN TRUST CORP | 76,423 | $741,303 | +526% | 13F |
| DAFNA Capital Management LLC | 67,101 | $650,880 | New | 13F |
| Quadrature Capital Ltd | 49,345 | $478,647 | New | 13F |
| DIMENSIONAL FUND ADVISORS LP | 44,815 | $434,705 | +120% | 13F |
| XTX Topco Ltd | 42,509 | $412,337 | +110% | 13F |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 31,113 | $301,796 | New | 13F |
| Velan Capital Investment Management LP | 25,000 | $242,500 | +0% | 13F |
| Atom Investors LP | 22,854 | $221,684 | New | 13F |
| BAILARD, INC. | 20,700 | $200,790 | +0% | 13F |
| Spark Investment Management LLC | 16,500 | $160,050 | New | 13F |
| GOLDMAN SACHS GROUP INC | 15,780 | $153,066 | +38% | 13F |
| Squarepoint Ops LLC | 14,855 | $144,094 | New | 13F |
| ALLIANCEBERNSTEIN L.P. | 13,980 | $135,606 | New | 13F |
| Vanguard Global Advisers, LLC | 11,978 | $116,187 | New | 13F |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11,896 | $115,391 | New | 13F |
| NEW YORK STATE COMMON RETIREMENT FUND | 6,100 | $59,170 | New | 13F |
| Russell Investments Group, Ltd. | 5,861 | $56,852 | +7% | 13F |
| WELLS FARGO & COMPANY/MN | 5,480 | $53,156 | +265% | 13F |
| State of Wyoming | 4,588 | $44,504 | New | 13F |
| JPMORGAN CHASE & CO | 4,191 | $40,149 | +1779% | 13F |
| FMR LLC | 3,558 | $34,513 | +1% | 13F |
| BARCLAYS PLC | 3,336 | $32,359 | New | 13F |
| ROYAL BANK OF CANADA | 3,066 | $30,000 | +1531% | 13F |
| RHUMBLINE ADVISERS | 3,039 | $29,474 | New | 13F |
| MORGAN STANLEY | 2,212 | $21,457 | -86% | 13F |
| CITIGROUP INC | 2,143 | $20,788 | New | 13F |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | 2,136 | $20,719 | New | 13F |
| Federation des caisses Desjardins du Quebec | 2,000 | $19,400 | New | 13F |
| China Universal Asset Management Co., Ltd. | 1,600 | $15,520 | New | 13F |
| BNP PARIBAS FINANCIAL MARKETS | 1,148 | $11,136 | +112% | 13F |
| Legal & General Group Plc | 566 | $5,490 | New | 13F |
| Steward Partners Investment Advisory, LLC | 500 | $4,850 | New | 13F |
| Ameritas Investment Partners, Inc. | 421 | $4,084 | New | 13F |
| MARK SHEPTOFF FINANCIAL PLANNING, LLC | 400 | $3,880 | +0% | 13F |
| Tower Research Capital LLC (TRC) | 247 | $2,396 | New | 13F |
| US BANCORP \DE\ | 235 | $2,280 | New | 13F |
| Quarry LP | 94 | $912 | New | 13F |
| Sterling Capital Management LLC | 72 | $698 | New | 13F |
| ACADIAN ASSET MANAGEMENT LLC | 22,940 | $221 | New | 13F |
| Caitong International Asset Management Co., Ltd | 13 | $126 | New | 13F |
| JONES FINANCIAL COMPANIES LLLP | 11 | $106 | New | 13F |
Questions and answers
- How many institutions hold Artiva Biotherapeutics, Inc.?
- 72 managers reported Artiva Biotherapeutics, Inc. on Form 13F for the quarter ended 30 June 2026, against 40 the quarter before.
- Who is the largest institutional holder of Artiva Biotherapeutics, Inc.?
- RA CAPITAL MANAGEMENT, L.P., with 17,955,642 shares worth $174 million on its 13F for Q2 2026.
- How many institutions bought or sold out of Artiva Biotherapeutics, Inc. in Q2 2026?
- 39 managers reported a new position and 7 reported none after holding it the quarter before.
Source: SEC EDGAR, Form 13F (public domain). Counts and values as filed. Cite this page: Tamarly Intelligence, "Who holds Artiva Biotherapeutics, Inc., Q2 2026", https://app.tamarly.ai/holders/artiva-biotherapeutics, built from SEC EDGAR.
Research from public records, not investment advice. Tamarly holds no investment positions. By reading these pages you accept the Terms of Use; figures can be late or wrong, so check the linked source before relying on one. Terms and policies.